CIGARETTE-SMOKE INCREASES BUPIVACAINE METABOLISM IN RATS

被引:7
作者
BRUGUEROLLE, B
ATTOLINI, L
ROUCOULES, X
LOREC, AM
机构
[1] Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine de Marseille, Marseille cedex 5, F 13385, Bd J. Moulin
来源
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE | 1994年 / 41卷 / 08期
关键词
ANESTHETICS; LOCAL; BUPIVACAINE; COMPLICATIONS; SMOKING; CIGARETTES; PHARMACOKINETICS; KINETICS; METABOLISM;
D O I
10.1007/BF03015630
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
This study was designed to document possible changes in bupivacaine kinetics in rats after exposure to cigarette smoke. Rats (n = 15) were exposed to cigarette smoke (Borgwaldt type Hamburg II)for ten minutes per day during four days (C) or eight days (B); controls (A) were used simultaneously without exposure to cigarette smoke. After bupivacaine 20 mg.kg(-1) ip at day 4 (C) or day 8 (B), blood was sampled (0.5 ml of blood collected by puncture at the retro-orbital sinus 0.25, 0.5, 1, 2, 4, 6 and 8 hours after administration) and bupivacaine and its main metabolite i.e., desbutylbupivacaine (PPX) were determined by gas liquid chromatography. The sensitivity of the method was 15 ng.ml(-1) and the reproductibility was <6%. Serum bupivacaine concentrations were plotted against time and the pharmacokinetic variables were determined assuming a two compartment open model: Cmax, Tmax were derived directly from individual data. The beta phase elimination half-lives (T(1/2)beta), the area under the serum concentration curve (AUC(0)(infinity)), the total plasma clearance (CI) and the total volume of distribution (Vd) were calculated. These variables were assessed according to non-linear fitting method. Cigarette smoking exposure did not change the pharmacokinetic variables of bupivacaine. However the pharmacokinetic parameters of PPX, Cmax (0.175 +/- 0.007 mu g.ml(-1), 0.119 +/- 0.014 mu g.ml(-1) and 0.312 +/- 0.023 mu g.ml(-1), for groups A, B and C, respectively), AUC (0.170 +/- 0.006 mu g.ml(-1).hr(-1), 0.104 +/- 0.013 mu g.ml(-1.)hr(-1) and 0.433 +/- 0.017 mu g.ml(-1.)hr(-1) for groups A, B and C, respectively) and the ratio AUC PPX/ AUC bupivacaine (0.306 +/- 0.042, 0.153 +/- 0.021 and 0.660 +/- 0.054 for groups A, B and C, respectively were higher (P < 0.0001) for group C. These results indicate an enzymatic induction after only short exposure to cigarette smoking and justify further studies to document possible variations of the metabolism of bupivacaine induced by exposure to cigarette smoke in humans.
引用
收藏
页码:733 / 737
页数:5
相关论文
共 11 条
[1]   COMPARATIVE-EVALUATION OF STIMULATORY EFFECTS OF ORAL TOBACCO AND NICOTINE CONSUMPTION ON HEPATIC-MICROSOMAL N-DEMETHYLATIONS [J].
ALI, B ;
KAUR, S ;
KUMAR, A ;
BHARGAVA, KP .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (22) :3087-3092
[2]   CAPILLARY GAS-CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS DETERMINATION OF LOCAL-ANESTHETICS IN PLASMA SAMPLES [J].
BJORK, M ;
PETTERSSON, KJ ;
OSTERLOF, G .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 533 :229-234
[3]  
BRUGUEROLLE B, 1991, J PHARM PHARMACOL, V44, P440
[4]   THE EFFECTS OF AGE AND SMOKING ON THE PLASMA-PROTEIN BINDING OF LIGNOCAINE AND DIAZEPAM [J].
DAVIS, D ;
GROSSMAN, SH ;
KITCHELL, BB ;
SHAND, DG ;
ROUTLEDGE, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (02) :261-265
[5]  
DAWSON GW, 1982, PHARMACOL THERAPEUT, V15, P207
[6]   EFFECTS OF STANDARD CIGARETTE AND NICOTINE-LESS CIGARETTE-SMOKE INHALINGS ON NICORANDIL PLASMA-LEVELS IN RATS [J].
GOMITA, Y ;
ETO, K ;
FURUNO, K ;
ARAKI, Y .
PHARMACOLOGY, 1990, 40 (06) :312-317
[7]   EFFECT OF CIGARETTE-SMOKING ON THEOPHYLLINE PHARMACOKINETICS IN RATS [J].
GOMITA, Y ;
FURUNO, K ;
ETO, K ;
OKAZAKI, M ;
SUEMARU, K ;
ARAKI, Y .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (09) :621-624
[8]   EFFECT OF CIGARETTE-SMOKING ON HEPATIC BIOTRANSFORMATIONS IN RATS [J].
GRAZIANO, MJ ;
DOROUGH, HW .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1984, 75 (02) :229-239
[9]   EFFECT OF SMOKING ON BINDING OF LIDOCAINE TO HUMAN-SERUM PROTEINS [J].
MCNAMARA, PJ ;
SLAUGHTER, RL ;
VISCO, JP ;
ELWOOD, CM ;
SIEGEL, JH ;
LALKA, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (06) :749-751
[10]  
RAUNIO H, 1983, ACTA PHARMACOL TOX, V52, P168